Meituan
HKEX:3690
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
62.55
213.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Meituan
Current Assets | 170.3B |
Cash & Short-Term Investments | 133.3B |
Receivables | 12.1B |
Other Current Assets | 24.9B |
Non-Current Assets | 115.3B |
Long-Term Investments | 49.9B |
PP&E | 29.8B |
Intangibles | 30.3B |
Other Non-Current Assets | 5.2B |
Current Liabilities | 94.3B |
Accounts Payable | 23B |
Accrued Liabilities | 6.7B |
Short-Term Debt | 10.8B |
Other Current Liabilities | 53.8B |
Non-Current Liabilities | 30.7B |
Long-Term Debt | 29.2B |
Other Non-Current Liabilities | 1.6B |
Balance Sheet
Meituan
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
16 804
|
9 377
|
19 408
|
17 043
|
13 396
|
17 093
|
32 514
|
20 158
|
33 340
|
|
Cash |
15 804
|
9 327
|
16 129
|
11 467
|
7 101
|
15 788
|
20 642
|
14 125
|
29 942
|
|
Cash Equivalents |
1 000
|
50
|
3 279
|
5 576
|
6 295
|
1 305
|
11 872
|
6 033
|
3 397
|
|
Short-Term Investments |
784
|
12 608
|
25 863
|
41 830
|
49 436
|
43 999
|
84 282
|
91 873
|
111 821
|
|
Total Receivables |
719
|
685
|
3 878
|
7 828
|
8 888
|
12 437
|
14 256
|
12 248
|
13 260
|
|
Accounts Receivables |
278
|
266
|
1 320
|
702
|
1 338
|
1 623
|
2 724
|
3 529
|
4 858
|
|
Other Receivables |
441
|
419
|
2 558
|
7 126
|
7 550
|
10 814
|
11 532
|
8 719
|
8 401
|
|
Inventory |
8
|
37
|
88
|
400
|
275
|
466
|
682
|
1 163
|
1 305
|
|
Other Current Assets |
3 558
|
929
|
5 200
|
6 048
|
10 140
|
14 310
|
16 095
|
17 703
|
23 391
|
|
Total Current Assets |
21 874
|
23 635
|
54 438
|
73 149
|
82 135
|
88 306
|
147 829
|
143 145
|
183 116
|
|
PP&E Net |
446
|
511
|
916
|
4 077
|
5 536
|
15 273
|
23 718
|
22 941
|
26 791
|
|
PP&E Gross |
446
|
511
|
916
|
4 077
|
5 536
|
15 273
|
23 718
|
22 941
|
26 791
|
|
Accumulated Depreciation |
116
|
365
|
679
|
4 848
|
7 629
|
8 783
|
15 095
|
19 038
|
21 756
|
|
Intangible Assets |
4 009
|
4 195
|
4 983
|
6 170
|
4 994
|
4 029
|
3 318
|
2 869
|
2 624
|
|
Goodwill |
13 780
|
14 954
|
14 870
|
27 706
|
27 706
|
27 647
|
27 731
|
27 774
|
27 774
|
|
Note Receivable |
7
|
1
|
222
|
370
|
972
|
801
|
1 269
|
3 258
|
2 375
|
|
Long-Term Investments |
2 669
|
7 955
|
7 872
|
8 345
|
9 650
|
24 657
|
34 202
|
42 091
|
47 612
|
|
Other Long-Term Assets |
105
|
467
|
334
|
844
|
1 020
|
5 862
|
2 587
|
2 403
|
2 737
|
|
Other Assets |
13 780
|
14 954
|
14 870
|
27 706
|
27 706
|
27 647
|
27 731
|
27 774
|
27 774
|
|
Total Assets |
42 890
N/A
|
51 717
+21%
|
83 634
+62%
|
120 662
+44%
|
132 013
+9%
|
166 575
+26%
|
240 653
+44%
|
244 481
+2%
|
293 030
+20%
|
|
Liabilities | ||||||||||
Accounts Payable |
442
|
1 300
|
2 667
|
5 341
|
6 766
|
11 967
|
15 166
|
17 379
|
22 981
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
3 968
|
5 649
|
7 226
|
7 964
|
7 898
|
|
Short-Term Debt |
0
|
1
|
162
|
1 800
|
3 190
|
3 250
|
2 140
|
17 562
|
0
|
|
Current Portion of Long-Term Debt |
0
|
1 274
|
0
|
0
|
897
|
4 235
|
11 182
|
2 166
|
21 802
|
|
Other Current Liabilities |
9 801
|
9 901
|
17 689
|
24 684
|
21 771
|
26 047
|
32 879
|
31 358
|
48 194
|
|
Total Current Liabilities |
10 243
|
12 476
|
20 517
|
31 825
|
36 593
|
51 148
|
68 593
|
76 430
|
100 874
|
|
Long-Term Debt |
49 874
|
62 413
|
101 418
|
470
|
1 459
|
16 572
|
45 597
|
38 360
|
38 819
|
|
Deferred Income Tax |
443
|
1 173
|
1 050
|
1 196
|
1 388
|
756
|
896
|
846
|
968
|
|
Minority Interest |
0
|
47
|
58
|
5
|
58
|
59
|
57
|
56
|
57
|
|
Other Liabilities |
0
|
1 230
|
1 150
|
661
|
519
|
465
|
11
|
140
|
412
|
|
Total Liabilities |
60 560
N/A
|
77 339
+28%
|
124 193
+61%
|
34 157
-72%
|
39 900
+17%
|
68 882
+73%
|
115 040
+67%
|
115 720
+1%
|
141 016
+22%
|
|
Equity | ||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
25 052
|
30 260
|
49 398
|
163 663
|
160 809
|
155 188
|
175 223
|
178 791
|
164 650
|
|
Additional Paid In Capital |
8 464
|
8 568
|
9 339
|
258 285
|
260 360
|
263 155
|
311 221
|
316 743
|
325 579
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
84
|
0
|
0
|
0
|
|
Other Equity |
1 082
|
3 930
|
500
|
8 118
|
7 439
|
10 359
|
10 386
|
9 191
|
8 916
|
|
Total Equity |
17 670
N/A
|
25 622
-45%
|
40 559
-58%
|
86 504
N/A
|
92 112
+6%
|
97 693
+6%
|
125 613
+29%
|
128 762
+3%
|
152 013
+18%
|
|
Total Liabilities & Equity |
42 890
N/A
|
51 717
+21%
|
83 634
+62%
|
120 662
+44%
|
132 013
+9%
|
166 575
+26%
|
240 653
+44%
|
244 481
+2%
|
293 030
+20%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
1 482
|
1 484
|
1 549
|
5 493
|
5 808
|
5 885
|
6 136
|
6 193
|
6 244
|